Ambrosia Biosciences
Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders
$100MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Pitching Blue Owl Healthcare Opportunities? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room